Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
PTC THERAPEUTICS, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago
Item 2 Issuer Principal Place of Business and Contact Information
100 CORPORATE COURT
SOUTH PLAINFIELD, NJ 07080-2449
Phone Number:
subscription required
Item 3. Related Persons
Name
STUART W. PELTZ
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
CLAUDIA HIRAWAT
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MARK E. BOULDING
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ALLAN S. JACOBSON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL SCHMERTZLER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DAVID P. SOUTHWELL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GEOFFREY MCDONOUGH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ADAM KOPPEL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL KRANDA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
AXEL BOLTE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEROME B. ZELDIS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RICHARD ALDRICH
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
05/14/2013
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
CREDIT SUISSE SECURITIES (USA) LLC
Recipient CRD Number
816
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
11 MADISON AVENUE
24TH FLOOR
NEW YORK, NY 10010
States of Solicitation
Item 12. Sales Compensation
Recipient
WEDBUSH SECURITIES INC.
Recipient CRD Number
877
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1000 WILSHIRE BOULEVARD
LOS ANGELES, CA 90017
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
4500000
Total Amount Sold
4500000
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
315000.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
PTC THERAPEUTICS, INC.
Issuer Signature
/S/ MARK E. BOULDING
Signer Name
MARK E. BOULDING
Signer Title
EXECUTIVE VICE PRESIDENT AND CHIEF LEGAL OFFICER
Signature Date
05/15/2013